Is the pharmacology management of CHF different in men and women and if so how?
Instructions
Beyond answering the question include nursing Implications which are the nursing related consequences and what should be the treatment and care of the patient. Identify the pharmacodynamic properties and actual/potential effects on the patient
Answer
Differences in Pharmacologic Management of CHF in Men and Women Incidence of congestive heart failure is on a rise globally. In the U.S, nearly half of the people diagnosed with heart failure are females. The genetic composition of male and females is different. The lifetime risk of heart failure at age 40 years without a prior myocardial infarction in the United States is 11% in men and 15% in women (Eisenberg et al, 2018). The incidence, prevalence, diagnosis, and treatment of heart failure vary according to gender. Pharmacologic management is the mainstay treatment for congestive heart failure but the pharmacokinetics, pharmacodynamics, and response of the drugs vary according to sex. Pharmacotherapy Differences Based on SexPharmacokinetics and pharmacodynamics of CHF are affected by se...
To avoid plagiarism, part of the answer is hidden. Click on the button below to order the full answer.
Order Answer
Back
Price Calculator
Manage orders
Why we are Ranked the best
- Unlimited Revisions
- Free 24/7 Support and chat
- Money back guaranteed
- Low prices with discounts
- Experienced writers.
- Free Unlimited support